Strona główna・Stock List・iRhythm Technologies Inc

iRhythm Technologies Inc

Open

SectorHealthcare

127.24 2.23

Buy Sell

Overview

Share price change

24h

Current

Min

123.51

Max

127.16

Key metrics
By Trading Economics
Income	-20M -14M
Sales	-9.5M 199M
EPS	-0.35
Profit margin	-6.988
Employees	2,400
EBITDA	-20M -3.6M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+40.29% upside

Dividends
By Acuity
Next Earnings	6 sie 2026

Market Stats
By TradingEconomics
Market Cap	-453M 3.7B
Previous open	125.01
Previous close	127.24

News Sentiment

By Acuity

50%

151 / 340 Ranking in Healthcare

iRhythm Technologies Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 sie 2026, 20:03 UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31 lip 2026, 21:01 UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30 lip 2026, 19:43 UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29 lip 2026, 19:52 UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28 lip 2026, 18:03 UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27 lip 2026, 20:06 UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24 lip 2026, 20:06 UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23 lip 2026, 09:01 UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21 lip 2026, 18:56 UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20 lip 2026, 19:16 UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Peer Comparison

Price change

iRhythm Technologies Inc Forecast

Price Target

By TipRanks

40.29% upside

12 Months Forecast

Average 174.88 USD 40.29%

High 255 USD

Low 150 USD

Based on 9 Wall Street analysts offering 12 month price targets foriRhythm Technologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to iRhythm Technologies Inc - Dist in the past 3 months.

Sentiment

By Acuity

151 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.